Guggenheim Capital LLC Tekla Life Sciences Investors Transaction History

Guggenheim Capital LLC

$13.3 Billion
Q3 2025

A detailed history of Guggenheim Capital LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Guggenheim Capital LLC holds 26,485 shares of HQL stock, worth $440,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,485

Previous 27,783 4.67%

Holding current value

$440,975

Previous $355,000 15.49%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$12.76 - $15.51 $16,562 - $20,131	-1,298 Reduced 4.67%	26,485 $410,000
Q2 2025 Aug 13, 2025	SELL	$10.87 - $13.02 $6,185 - $7,408	-569 Reduced 2.01%	27,783 $355,000
Q1 2025 May 14, 2025	BUY	$12.69 - $14.36 $156,074 - $176,613	12,299 Added 76.61%	28,352 $359,000
Q4 2024 Feb 13, 2025	BUY	$13.12 - $15.25 $210,615 - $244,808	16,053 New	16,053 $210,000
Q2 2024 Aug 14, 2024	BUY	$12.79 - $14.27 $24,070 - $26,856	1,882 Added 7.34%	27,505 $389,000

Q1 2024 May 14, 2024	SELL	$13.38 - $14.33 $47,686 - $51,072	-3,564 Reduced 12.21%	25,623 $349,000
Q4 2023 Feb 14, 2024	BUY	$11.35 - $13.6 $12,246 - $14,674	1,079 Added 3.84%	29,187 $392,000
Q3 2023 Nov 14, 2023	BUY	$12.38 - $13.69 $1,386 - $1,533	112 Added 0.4%	28,108 $350,000
Q2 2023 Aug 11, 2023	BUY	$13.13 - $14.17 $39,665 - $42,807	3,021 Added 12.1%	27,996 $379,000
Q1 2023 May 10, 2023	BUY	$13.37 - $14.94 $190,402 - $212,760	14,241 Added 132.67%	24,975 $347,000
Q4 2022 Feb 14, 2023	BUY	$13.55 - $15.23 $145,445 - $163,478	10,734 New	10,734 $152,000
Q1 2022 May 16, 2022	SELL	$15.35 - $19.29 $165,657 - $208,177	-10,792 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$18.5 - $21.59 $217,541 - $253,876	-11,759 Reduced 52.14%	10,792 $208,000
Q3 2021 Nov 15, 2021	BUY	$20.27 - $22.67 $891 - $997	44 Added 0.2%	22,551 $469,000
Q2 2021 Aug 13, 2021	SELL	$19.14 - $21.44 $33,686 - $37,734	-1,760 Reduced 7.25%	22,507 $483,000
Q1 2021 May 13, 2021	SELL	$19.31 - $22.07 $20,816 - $23,791	-1,078 Reduced 4.25%	24,267 $479,000
Q4 2020 Feb 16, 2021	SELL	$16.8 - $20.21 $1,932 - $2,324	-115 Reduced 0.45%	25,345 $500,000
Q3 2020 Nov 13, 2020	BUY	$16.71 - $19.06 $57,365 - $65,432	3,433 Added 15.59%	25,460 $447,000
Q2 2020 Aug 14, 2020	SELL	$14.22 - $18.38 $123,458 - $159,575	-8,682 Reduced 28.27%	22,027 $396,000
Q1 2020 Jun 02, 2020	BUY	$12.22 - $17.99 $81,311 - $119,705	6,654 Added 27.66%	30,709 $460,000
Q4 2019 Feb 14, 2020	BUY	$14.63 - $17.84 $107,823 - $131,480	7,370 Added 44.17%	24,055 $419,000
Q3 2019 Nov 14, 2019	SELL	$15.09 - $17.09 $16,810 - $19,038	-1,114 Reduced 6.26%	16,685 $252,000
Q2 2019 Aug 14, 2019	SELL	$15.54 - $17.47 $1,351 - $1,519	-87 Reduced 0.49%	17,799 $300,000
Q1 2019 May 15, 2019	SELL	$15.5 - $17.9 $7,967 - $9,200	-514 Reduced 2.79%	17,886 $306,000
Q4 2018 Feb 14, 2019	BUY	$13.99 - $20.35 $58,128 - $84,554	4,155 Added 29.17%	18,400 $278,000
Q3 2018 Nov 14, 2018	BUY	$18.89 - $20.49 $269,088 - $291,880	14,245 New	14,245 $291,000

Others Institutions Holding HQL

# of Institutions

Shares Held

9.38M

Call Options Held

Put Options Held

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Tekla Life Sciences Investors Transaction History